Nanexa
0,96 SEK +2,35%3 investorer følger denne virksomhed
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NANEXA
Daglig lav / høj pris
0,94 / 0,97
SEK
Markedsværdi
130,27 mio. SEK
Aktieomsætning
70 t SEK
Volumen
74 t
Seneste videoer
Finanskalender
Delårsrapport
27.08.2024
Delårsrapport
07.11.2024
Årsrapport
19.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Novo Nordisk A/S | 19,9 % | 19,9 % |
Avanza Pension | 5,7 % | 5,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
First patient dosed in Nanexa's Phase I trial of NEX-22 in type 2 diabetes
Bulletin from Nanexa’s Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools